COVID-19 vaccine study reveals immune response in people with HIV
NCT ID NCT06731127
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examined how the COVID-19 vaccine affects the immune system in people with HIV compared to those without HIV. Researchers followed 75 participants aged 55 and older for 48 weeks, taking blood and saliva samples. The goal was to understand vaccine effectiveness and any changes in HIV levels, but no new treatment or vaccine was given.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Maple Leaf Medical Clinic
Toronto, Ontario, M5G 1K2, Canada